0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Mental Disorder Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-34D4133
Home | Market Reports | Health| Mental Health
Global Mental Disorder Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Mental Disorder Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-34D4133
Report
October 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mental Disorder Treatment - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Mental Disorder Treatment - Market

Mental Disorder Treatment - Market

A mental disorder is also called as mental illness or a psychiatric disorder. Mental disorders are generally defined according to how an individual behave, feels, perceives and thinks, and mental disorder occurs due to damage or problems associated with functions of brain. There are various types of mental disorders such as depression, bipolar disorder, schizophrenia and other psychoses, dementia, and developmental disorders including autism.
These disorders can be treated with the help of various medications such as anti-depressants, antianxiety drugs and can also be treated with self-help therapies such as psychotherapy, brain stimulation treatments, and others.
The global market for Mental Disorder Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mental Disorder Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Mental Disorder Treatment by region & country, by Type, and by Application.
The Mental Disorder Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mental Disorder Treatment.
Market Segmentation

Scope of Mental Disorder Treatment - Market Report

Report Metric Details
Report Name Mental Disorder Treatment - Market
CAGR 5%
Segment by Type:
  • Medications
  • Self-help Therapies
Segment by Application
  • Depression
  • Bipolar Disorder
  • Schizophrenia
  • Dementia
  • Post-traumatic Stress Disorder
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Allergan Plc, Eli Lilly and Company, VistaGen Therapeutics, Sanofi S.A, Novartis International AG, Mylan N.V, Amneal Pharmaceuticals LLC, Cipla Ltd, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Limited, Lupin Limited, Janssen Pharmaceutica, Bristol Myers Squibb, Sumitomo Dainippon Pharma Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Mental Disorder Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Mental Disorder Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Mental Disorder Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Mental Disorder Treatment - Market report?

Ans: The main players in the Mental Disorder Treatment - Market are Allergan Plc, Eli Lilly and Company, VistaGen Therapeutics, Sanofi S.A, Novartis International AG, Mylan N.V, Amneal Pharmaceuticals LLC, Cipla Ltd, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Limited, Lupin Limited, Janssen Pharmaceutica, Bristol Myers Squibb, Sumitomo Dainippon Pharma Co., Ltd

What are the Application segmentation covered in the Mental Disorder Treatment - Market report?

Ans: The Applications covered in the Mental Disorder Treatment - Market report are Depression, Bipolar Disorder, Schizophrenia, Dementia, Post-traumatic Stress Disorder, Others

What are the Type segmentation covered in the Mental Disorder Treatment - Market report?

Ans: The Types covered in the Mental Disorder Treatment - Market report are Medications, Self-help Therapies

Recommended Reports

Mental Health Treatments

Disorder Therapy Markets

Neurodevelopmental Disorders

1 Market Overview
1.1 Mental Disorder Treatment Product Introduction
1.2 Global Mental Disorder Treatment Market Size Forecast
1.3 Mental Disorder Treatment Market Trends & Drivers
1.3.1 Mental Disorder Treatment Industry Trends
1.3.2 Mental Disorder Treatment Market Drivers & Opportunity
1.3.3 Mental Disorder Treatment Market Challenges
1.3.4 Mental Disorder Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Mental Disorder Treatment Players Revenue Ranking (2023)
2.2 Global Mental Disorder Treatment Revenue by Company (2019-2024)
2.3 Key Companies Mental Disorder Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Mental Disorder Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Mental Disorder Treatment
2.6 Mental Disorder Treatment Market Competitive Analysis
2.6.1 Mental Disorder Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Mental Disorder Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Disorder Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Medications
3.1.2 Self-help Therapies
3.2 Global Mental Disorder Treatment Sales Value by Type
3.2.1 Global Mental Disorder Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Mental Disorder Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Mental Disorder Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Depression
4.1.2 Bipolar Disorder
4.1.3 Schizophrenia
4.1.4 Dementia
4.1.5 Post-traumatic Stress Disorder
4.1.6 Others
4.2 Global Mental Disorder Treatment Sales Value by Application
4.2.1 Global Mental Disorder Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Mental Disorder Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Mental Disorder Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Mental Disorder Treatment Sales Value by Region
5.1.1 Global Mental Disorder Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Mental Disorder Treatment Sales Value by Region (2019-2024)
5.1.3 Global Mental Disorder Treatment Sales Value by Region (2025-2030)
5.1.4 Global Mental Disorder Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Mental Disorder Treatment Sales Value, 2019-2030
5.2.2 North America Mental Disorder Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Mental Disorder Treatment Sales Value, 2019-2030
5.3.2 Europe Mental Disorder Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Mental Disorder Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Mental Disorder Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Mental Disorder Treatment Sales Value, 2019-2030
5.5.2 South America Mental Disorder Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Mental Disorder Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Mental Disorder Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Mental Disorder Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Mental Disorder Treatment Sales Value
6.3 United States
6.3.1 United States Mental Disorder Treatment Sales Value, 2019-2030
6.3.2 United States Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Mental Disorder Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Mental Disorder Treatment Sales Value, 2019-2030
6.4.2 Europe Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Mental Disorder Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Mental Disorder Treatment Sales Value, 2019-2030
6.5.2 China Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Mental Disorder Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Mental Disorder Treatment Sales Value, 2019-2030
6.6.2 Japan Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Mental Disorder Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Mental Disorder Treatment Sales Value, 2019-2030
6.7.2 South Korea Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Mental Disorder Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Mental Disorder Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Mental Disorder Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Mental Disorder Treatment Sales Value, 2019-2030
6.9.2 India Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Mental Disorder Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Allergan Plc
7.1.1 Allergan Plc Profile
7.1.2 Allergan Plc Main Business
7.1.3 Allergan Plc Mental Disorder Treatment Products, Services and Solutions
7.1.4 Allergan Plc Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Allergan Plc Recent Developments
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Profile
7.2.2 Eli Lilly and Company Main Business
7.2.3 Eli Lilly and Company Mental Disorder Treatment Products, Services and Solutions
7.2.4 Eli Lilly and Company Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Eli Lilly and Company Recent Developments
7.3 VistaGen Therapeutics
7.3.1 VistaGen Therapeutics Profile
7.3.2 VistaGen Therapeutics Main Business
7.3.3 VistaGen Therapeutics Mental Disorder Treatment Products, Services and Solutions
7.3.4 VistaGen Therapeutics Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Sanofi S.A Recent Developments
7.4 Sanofi S.A
7.4.1 Sanofi S.A Profile
7.4.2 Sanofi S.A Main Business
7.4.3 Sanofi S.A Mental Disorder Treatment Products, Services and Solutions
7.4.4 Sanofi S.A Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Sanofi S.A Recent Developments
7.5 Novartis International AG
7.5.1 Novartis International AG Profile
7.5.2 Novartis International AG Main Business
7.5.3 Novartis International AG Mental Disorder Treatment Products, Services and Solutions
7.5.4 Novartis International AG Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Novartis International AG Recent Developments
7.6 Mylan N.V
7.6.1 Mylan N.V Profile
7.6.2 Mylan N.V Main Business
7.6.3 Mylan N.V Mental Disorder Treatment Products, Services and Solutions
7.6.4 Mylan N.V Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Mylan N.V Recent Developments
7.7 Amneal Pharmaceuticals LLC
7.7.1 Amneal Pharmaceuticals LLC Profile
7.7.2 Amneal Pharmaceuticals LLC Main Business
7.7.3 Amneal Pharmaceuticals LLC Mental Disorder Treatment Products, Services and Solutions
7.7.4 Amneal Pharmaceuticals LLC Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Amneal Pharmaceuticals LLC Recent Developments
7.8 Cipla Ltd
7.8.1 Cipla Ltd Profile
7.8.2 Cipla Ltd Main Business
7.8.3 Cipla Ltd Mental Disorder Treatment Products, Services and Solutions
7.8.4 Cipla Ltd Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Cipla Ltd Recent Developments
7.9 Sun Pharmaceutical Industries Ltd
7.9.1 Sun Pharmaceutical Industries Ltd Profile
7.9.2 Sun Pharmaceutical Industries Ltd Main Business
7.9.3 Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Products, Services and Solutions
7.9.4 Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Sun Pharmaceutical Industries Ltd Recent Developments
7.10 Glenmark Pharmaceuticals Limited
7.10.1 Glenmark Pharmaceuticals Limited Profile
7.10.2 Glenmark Pharmaceuticals Limited Main Business
7.10.3 Glenmark Pharmaceuticals Limited Mental Disorder Treatment Products, Services and Solutions
7.10.4 Glenmark Pharmaceuticals Limited Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Glenmark Pharmaceuticals Limited Recent Developments
7.11 Lupin Limited
7.11.1 Lupin Limited Profile
7.11.2 Lupin Limited Main Business
7.11.3 Lupin Limited Mental Disorder Treatment Products, Services and Solutions
7.11.4 Lupin Limited Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Lupin Limited Recent Developments
7.12 Janssen Pharmaceutica
7.12.1 Janssen Pharmaceutica Profile
7.12.2 Janssen Pharmaceutica Main Business
7.12.3 Janssen Pharmaceutica Mental Disorder Treatment Products, Services and Solutions
7.12.4 Janssen Pharmaceutica Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Janssen Pharmaceutica Recent Developments
7.13 Bristol Myers Squibb
7.13.1 Bristol Myers Squibb Profile
7.13.2 Bristol Myers Squibb Main Business
7.13.3 Bristol Myers Squibb Mental Disorder Treatment Products, Services and Solutions
7.13.4 Bristol Myers Squibb Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 Bristol Myers Squibb Recent Developments
7.14 Sumitomo Dainippon Pharma Co., Ltd
7.14.1 Sumitomo Dainippon Pharma Co., Ltd Profile
7.14.2 Sumitomo Dainippon Pharma Co., Ltd Main Business
7.14.3 Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Products, Services and Solutions
7.14.4 Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.14.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments
8 Industry Chain Analysis
8.1 Mental Disorder Treatment Industrial Chain
8.2 Mental Disorder Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Mental Disorder Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Mental Disorder Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Mental Disorder Treatment Market Trends
    Table 2. Mental Disorder Treatment Market Drivers & Opportunity
    Table 3. Mental Disorder Treatment Market Challenges
    Table 4. Mental Disorder Treatment Market Restraints
    Table 5. Global Mental Disorder Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Mental Disorder Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Mental Disorder Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Mental Disorder Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Mental Disorder Treatment
    Table 10. Global Mental Disorder Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Disorder Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Mental Disorder Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Mental Disorder Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Mental Disorder Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Mental Disorder Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Mental Disorder Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Mental Disorder Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Mental Disorder Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Mental Disorder Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Mental Disorder Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Mental Disorder Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Mental Disorder Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Mental Disorder Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Mental Disorder Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Mental Disorder Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Mental Disorder Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Mental Disorder Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Mental Disorder Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Mental Disorder Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Allergan Plc Basic Information List
    Table 32. Allergan Plc Description and Business Overview
    Table 33. Allergan Plc Mental Disorder Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Mental Disorder Treatment Business of Allergan Plc (2019-2024)
    Table 35. Allergan Plc Recent Developments
    Table 36. Eli Lilly and Company Basic Information List
    Table 37. Eli Lilly and Company Description and Business Overview
    Table 38. Eli Lilly and Company Mental Disorder Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Mental Disorder Treatment Business of Eli Lilly and Company (2019-2024)
    Table 40. Eli Lilly and Company Recent Developments
    Table 41. VistaGen Therapeutics Basic Information List
    Table 42. VistaGen Therapeutics Description and Business Overview
    Table 43. VistaGen Therapeutics Mental Disorder Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Mental Disorder Treatment Business of VistaGen Therapeutics (2019-2024)
    Table 45. VistaGen Therapeutics Recent Developments
    Table 46. Sanofi S.A Basic Information List
    Table 47. Sanofi S.A Description and Business Overview
    Table 48. Sanofi S.A Mental Disorder Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Mental Disorder Treatment Business of Sanofi S.A (2019-2024)
    Table 50. Sanofi S.A Recent Developments
    Table 51. Novartis International AG Basic Information List
    Table 52. Novartis International AG Description and Business Overview
    Table 53. Novartis International AG Mental Disorder Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Mental Disorder Treatment Business of Novartis International AG (2019-2024)
    Table 55. Novartis International AG Recent Developments
    Table 56. Mylan N.V Basic Information List
    Table 57. Mylan N.V Description and Business Overview
    Table 58. Mylan N.V Mental Disorder Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Mental Disorder Treatment Business of Mylan N.V (2019-2024)
    Table 60. Mylan N.V Recent Developments
    Table 61. Amneal Pharmaceuticals LLC Basic Information List
    Table 62. Amneal Pharmaceuticals LLC Description and Business Overview
    Table 63. Amneal Pharmaceuticals LLC Mental Disorder Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Mental Disorder Treatment Business of Amneal Pharmaceuticals LLC (2019-2024)
    Table 65. Amneal Pharmaceuticals LLC Recent Developments
    Table 66. Cipla Ltd Basic Information List
    Table 67. Cipla Ltd Description and Business Overview
    Table 68. Cipla Ltd Mental Disorder Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Mental Disorder Treatment Business of Cipla Ltd (2019-2024)
    Table 70. Cipla Ltd Recent Developments
    Table 71. Sun Pharmaceutical Industries Ltd Basic Information List
    Table 72. Sun Pharmaceutical Industries Ltd Description and Business Overview
    Table 73. Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Mental Disorder Treatment Business of Sun Pharmaceutical Industries Ltd (2019-2024)
    Table 75. Sun Pharmaceutical Industries Ltd Recent Developments
    Table 76. Glenmark Pharmaceuticals Limited Basic Information List
    Table 77. Glenmark Pharmaceuticals Limited Description and Business Overview
    Table 78. Glenmark Pharmaceuticals Limited Mental Disorder Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Mental Disorder Treatment Business of Glenmark Pharmaceuticals Limited (2019-2024)
    Table 80. Glenmark Pharmaceuticals Limited Recent Developments
    Table 81. Lupin Limited Basic Information List
    Table 82. Lupin Limited Description and Business Overview
    Table 83. Lupin Limited Mental Disorder Treatment Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Mental Disorder Treatment Business of Lupin Limited (2019-2024)
    Table 85. Lupin Limited Recent Developments
    Table 86. Janssen Pharmaceutica Basic Information List
    Table 87. Janssen Pharmaceutica Description and Business Overview
    Table 88. Janssen Pharmaceutica Mental Disorder Treatment Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Mental Disorder Treatment Business of Janssen Pharmaceutica (2019-2024)
    Table 90. Janssen Pharmaceutica Recent Developments
    Table 91. Bristol Myers Squibb Basic Information List
    Table 92. Bristol Myers Squibb Description and Business Overview
    Table 93. Bristol Myers Squibb Mental Disorder Treatment Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Mental Disorder Treatment Business of Bristol Myers Squibb (2019-2024)
    Table 95. Bristol Myers Squibb Recent Developments
    Table 96. Sumitomo Dainippon Pharma Co., Ltd Basic Information List
    Table 97. Sumitomo Dainippon Pharma Co., Ltd Description and Business Overview
    Table 98. Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Mental Disorder Treatment Business of Sumitomo Dainippon Pharma Co., Ltd (2019-2024)
    Table 100. Sumitomo Dainippon Pharma Co., Ltd Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Mental Disorder Treatment Downstream Customers
    Table 104. Mental Disorder Treatment Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Mental Disorder Treatment Product Picture
    Figure 2. Global Mental Disorder Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Mental Disorder Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Mental Disorder Treatment Report Years Considered
    Figure 5. Global Mental Disorder Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Mental Disorder Treatment Revenue in 2023
    Figure 7. Mental Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Medications Picture
    Figure 9. Self-help Therapies Picture
    Figure 10. Global Mental Disorder Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Mental Disorder Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Depression
    Figure 13. Product Picture of Bipolar Disorder
    Figure 14. Product Picture of Schizophrenia
    Figure 15. Product Picture of Dementia
    Figure 16. Product Picture of Post-traumatic Stress Disorder
    Figure 17. Product Picture of Others
    Figure 18. Global Mental Disorder Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Mental Disorder Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Mental Disorder Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Mental Disorder Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Mental Disorder Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Mental Disorder Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Mental Disorder Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Mental Disorder Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Mental Disorder Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Mental Disorder Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Mental Disorder Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Mental Disorder Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Mental Disorder Treatment Sales Value (%), (2019-2030)
    Figure 31. United States Mental Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Mental Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Mental Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Mental Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Mental Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Mental Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Mental Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Mental Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Mental Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Mental Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Mental Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Mental Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Mental Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Mental Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Mental Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 52. Mental Disorder Treatment Industrial Chain
    Figure 53. Mental Disorder Treatment Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS